Skip to main content

Table 1 Summary of patient characteristics, tumor volumes, and quantitative imaging parameter for all available datasets. Median value is reported for ADC map and pharmacokinetic parameters

From: Multi-parametric PET/MRI for enhanced tumor characterization of patients with cervical cancer

Patient

Age (years)

Weight (kg)

Histological type

HPV

FIGO stage

Tumor volume (cm3)

FDG-PET SUVmean

RGD-PET SUVmean

ADC 10−6 (mm2/s)

Ktrans (1/min)

ve

kep (1/min)

1

68

84

Squamous cell carcinoma

 + 

IIB

10.5

7.7

10.5

1097

128

144

80

2

29

54

Squamous cell carcinoma

 + 

IIIC

32.2

17.0

2.9

1199

78

96

79

3

65

76

Squamous cell carcinoma

Unknown

IIIC

30.5

9.8

4.7

941

104

151

65

4

68

78

Squamous cell carcinoma

 + 

IIB

20.3

9.5

6.4

1156

203

238

81

5

45

60

Adenocarcinoma

 + 

IB3

98.9

8.3

2.9

1176

139

141

94

6

60

70

Adenocarcinoma

 + 

IIIC1

125.8

15.7

5.1

1332

56

126

39

7

55

69

Squamous cell carcinoma

 + 

IIIC1

60.5

8.1

5.7

1368

156

207

73

8

41

100

Squamous cell carcinoma

 + 

IIIC1

120.3

11.5

NAN

935

89

130

66

9

46

65

Adenocarcinoma

 + 

IIIC1

55.9

7.8

6.3

1122

134

230

57

10

74

54

Squamous cell carcinoma

 + 

IIIB

32.1

5.9

7.1

991

90

167

58